Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 9106980)

Published in Z Gastroenterol on March 01, 1997

Authors

F Kullmann1, V Gross, J Rüschoff, H Arndt, W Benda, A Winkler von Mohrenfels, J Schölmerich

Author Affiliations

1: Department of Internal Medicine I, University of Regensburg, FRG.

Articles by these authors

Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology (2008) 5.31

Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res (1997) 4.61

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology (1996) 4.54

Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology (1998) 3.82

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology (2000) 3.46

Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology (1992) 3.17

Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83

Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol (2006) 2.81

Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet (1995) 2.81

Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80

Multiple mutation analyses in single tumor cells with improved whole genome amplification. Am J Pathol (1999) 2.62

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol (1997) 2.20

Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology (1993) 2.04

Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol (1999) 1.97

Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut (2005) 1.95

Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94

Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial. Endoscopy (1998) 1.83

Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77

Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut (1996) 1.73

Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest (1999) 1.71

Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem (1988) 1.69

Circular dichroism of ribonucleoprotein complexes from rat liver nuclei. Biochem Biophys Res Commun (1977) 1.69

Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol (1998) 1.68

Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta (2005) 1.66

Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res (1995) 1.65

Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid. Endoscopy (1998) 1.62

Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology (1991) 1.61

A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology (1990) 1.60

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. J Clin Pathol (2009) 1.58

Hair iron content: possible marker to complement monitoring therapy of iron deficiency in patients with chronic inflammatory bowel diseases? Clin Chem (1996) 1.56

The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J (2000) 1.52

Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. Gastroenterology (2001) 1.52

Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthritis Rheum (2002) 1.51

Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection (2010) 1.50

Use of self-expandable plastic stents for the treatment of esophageal perforations and symptomatic anastomotic leaks. Endoscopy (2004) 1.49

Hepatitis C - contamination of toothbrushes: myth or reality? J Viral Hepat (2006) 1.48

Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology (1999) 1.47

Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol (1997) 1.45

Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol (2003) 1.45

Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc (1999) 1.45

Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Am J Gastroenterol (1998) 1.45

Atrial natriuretic factor and digoxin-like immunoreactive factor in diabetic patients: their interrelation and the influence of the autonomic nervous system. J Clin Endocrinol Metab (1996) 1.43

[Fatal liver failure after corticosteroid treatment of a hepatitis B virus carrier]. Dtsch Med Wochenschr (1999) 1.43

Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res (1997) 1.43

Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol (1997) 1.42

Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev (2006) 1.41

Early shifts of adrenal steroid synthesis before and after relief of short-term cholestasis. J Hepatol (2001) 1.41

Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab (1998) 1.40

[Infections and vasculitis]. Z Rheumatol (1997) 1.40

Particle handling during interception feeding by four species of heterotrophic nanoflagellates. J Eukaryot Microbiol (2001) 1.40

Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med (1993) 1.40

Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol (1993) 1.39

[Chronic inflammatory bowel diseases: Crohn disease and ulcerative colitis. 1: Etiology and pathogenesis, diagnosis. Diagnostic imaging in Crohn disease]. Radiologe (2000) 1.39

Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (1999) 1.39

[A 63-year-old patient with worsening general condition, bone demineralization, hypocalcemia and excess parathyroid hormone: late manifestations of pseudohypohyperparathyroidism]. Dtsch Med Wochenschr (1999) 1.39

Wound healing and fibrosis in intestinal disease. Gut (2007) 1.38

Effect of swainsonine on the processing of the asparagine-linked carbohydrate chains of alpha 1-antitrypsin in rat hepatocytes. Evidence for the formation of hybrid oligosaccharides. J Biol Chem (1983) 1.35

Zooplankton-mediated changes of bacterial community structure. Microb Ecol (1994) 1.33

The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol (2000) 1.33

Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol (2007) 1.33

Hypertension-induced end-organ damage : A new transgenic approach to an old problem. Hypertension (1999) 1.32

Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. Dev Dyn (1997) 1.28

Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol (2006) 1.28

Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol (2000) 1.28

1-deoxynojirimycin impairs oligosaccharide processing of alpha 1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes. J Biol Chem (1983) 1.27

Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab (2000) 1.25

Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles. Hepatology (1984) 1.25

Differential activation of cytokine secretion in primary human colonic fibroblast/myofibroblast cultures. Scand J Gastroenterol (2001) 1.24

Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut (1999) 1.24

Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut (1997) 1.23

Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Gut (1997) 1.21

Skinned fibers of human atrium and ventricle: myosin isoenzymes and contractility. Circ Res (1988) 1.20

Apoptotic signaling during initiation of detachment-induced apoptosis ("anoikis") of primary human intestinal epithelial cells. Cell Growth Differ (2001) 1.18

Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg (1991) 1.15

Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1997) 1.15

Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int (1996) 1.15

Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest (1992) 1.14

Messenger RNA activities of four acute phase proteins during inflammation. FEBS Lett (1983) 1.14

Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation. Gut (2003) 1.14

Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis (2005) 1.14

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy. J Clin Pathol (2007) 1.13

Dengue virus infection transmitted by needle stick injury. J Infect (2002) 1.12